Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.23 USD
−119.38 M USD
18.89 M USD
85.44 M
About INVENTIVA
Sector
Industry
CEO
Frédéric Cren
Website
Headquarters
Daix
Founded
2011
FIGI
BBG00VM4C335
Inventiva SA is a clinical-stage biopharmaceutical company, which focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis, or NASH, and other diseases with significant unmet medical need. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centered on transcription factors, epigenetics targets, and nuclear receptors. The company was founded by Pierre Broqua and Frédéric Cren on October 27, 2011 and is headquartered in Daix, France.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.